One of the goals of the c4c project is to boost the quality of data gathered from the clinical trials run through the c4c project. This will provide us with information on how the c4c network is performing. Fondazione Gianni Benzi Onlus and Janssen Pharmaceutical NV are working to design and integrate IT systems and…
In c4c, we are thrilled to share the recent article from the Innovative Medicines Initiative (IMI) on how to make clinical trials more kid-friendly. This article highlights the importance of involving children and young people in the design and development of clinical trials, and includes first-hand experience from Joana Claverol, a member of the c4c PPI cross-cutting…
“Better medicines for babies, children and young people” is the ambitious aim of c4c. To realize this goal the project must first develop a pan-European, paediatric clinical trial network, and provide a wealth of support, tools and resources to build the infrastructure to deliver more efficient and effective paediatric clinical trials. The c4c consortium has…
The European Joint Programme for Rare Diseases has announced that 2020 will see the launch of a new funding call in pre-clinical research to develop effective therapies for rare diseases. The aim of the call is to enable scientists in different countries to build an effective collaboration on a common interdisciplinary research project…
Following the successful launch of the GCP training earlier this year, c4c will shortly be launching a new online course – Involving children and young patients and families’ in designing clinical research. This course is available to principle investigators and Patient and Public Involvement (PPI) liaisons in National Hubs, to support the inclusion of children…
A key concern of the c4c consortium is that strong communication and dissemination efforts need to be put in place in order to reach the widest possible audience. We are seeking experts specialised in communications that can assist in promoting project activities and bringing knowledge on paediatric research to the wider public. As a result, we are issuing…
‘RUN TO KICK’ is a fundraising initiative promoted by the Belgian Charity ‘KickCancer’. Taking place on 29th of September in Brussels, RUN TO KICK is an informal charity family race, without any time recording. Children and adolescents with cancer are an important topic for IMI. An IMI team is supporting this initiative and has chosen…
Project collaborators and Finnish National Hub, FinPedMed (Finnish Investigators Network for Paediatric Medicines), will coordinate the upcoming 3rd Nordic Conference on Paediatric Medicine, to be held on 8 – 9 October 2019 in Helsinki. The aim of the congress is to bring forward ideas for discussion in order to accelerate medicine development for children, by…
c4c (conect4children) is a large collaborative European network that aims to facilitate the development of new drugs and other therapies for the entire paediatric population. In this sense, the voices of children, young people and their families are a pivotal part of the innovative approach of c4c project. It places patients at the centre and will assign them an…
We are pleased to report that the book ‘Prescribing Medicines for Children: From drug development to practical administration’ has been launched. Co-edited by Prof. Mike Sharland and Prof. Mark Turner, in collaboration with Charlotte Barker, the textbook aims to improve understanding in all aspects of paediatric prescribing, from the development of suitable drugs through to…